Global Plasma Protein Therapeutics Market Size, Share, Growth Analysis Report - Forecast 2034

Plasma Protein Therapeutics Market

Plasma Protein Therapeutics Market By Product Type (C1 esterase Inhibitors, Albumins, Immunoglobulin, Coagulation Factors, and Others), By Application (Hereditary Angioedema, Hemophilia, Primary Immunodeficiency Disorder, Secondary Immunodeficiency, Idiopathic Thrombocytopenic, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Pharmaceutical Report Format : PDF Pages: 180 Report Code: ZMR-3310 Published Date: Apr-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 32.05 Billion USD 55.54 Billion 6.3% 2024

Plasma Protein Therapeutics Market

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Plasma Protein Therapeutics Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Plasma Protein Therapeutics Market : snapshot
  • Chapter 3. Global Plasma Protein Therapeutics Market - Industry Analysis
    • 3.1 Plasma Protein Therapeutics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing incidences of chronic diseases to foster the market growth
    • 3.3 Market Restraints
      • 3.3.1. Strict regulations in different countries to impede the market growth
    • 3.4 Market Opportunities
      • 3.4.1. High demand for Immunoglobulins (IG) to propel the market growth during the forecast period
    • 3.5 Market Challenges
      • 3.5.1. Unfavorable reimbursement policies to pose major challenge to market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product Type
      • 3.7.2 Market attractiveness analysis By Application
  • Chapter 4. Global Plasma Protein Therapeutics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Plasma Protein Therapeutics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Plasma Protein Therapeutics Market - Product Type Analysis
    • 5.1 Global Plasma Protein Therapeutics Market overview: By Product Type
      • 5.1.1 Global Plasma Protein Therapeutics Market share, By Product Type, 2021 and 2028
    • 5.2 C1 esterase Inhibitors
      • 5.2.1 Global Plasma Protein Therapeutics Market by C1 esterase Inhibitors, 2022 - 2028 (USD Billion)
    • 5.3 Albumins
      • 5.3.1 Global Plasma Protein Therapeutics Market by Albumins, 2022 - 2028 (USD Billion)
    • 5.4 Immunoglobulins
      • 5.4.1 Global Plasma Protein Therapeutics Market by Immunoglobulins, 2022 - 2028 (USD Billion)
    • 5.5 Coagulation Factors
      • 5.5.1 Global Plasma Protein Therapeutics Market by Coagulation Factors, 2022 - 2028 (USD Billion)
    • 5.6 Others
      • 5.6.1 Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Plasma Protein Therapeutics Market - Application Analysis
    • 6.1 Global Plasma Protein Therapeutics Market overview: By Application
      • 6.1.1 Global Plasma Protein Therapeutics Market share, By Application, 2021 and 2028
    • 6.2 Hereditary Angioedema
      • 6.2.1 Global Plasma Protein Therapeutics Market by Hereditary Angioedema, 2022 - 2028 (USD Billion)
    • 6.3 Hemophilia
      • 6.3.1 Global Plasma Protein Therapeutics Market by Hemophilia, 2022 - 2028 (USD Billion)
    • 6.4 Primary Immunodeficiency Disorder
      • 6.4.1 Global Plasma Protein Therapeutics Market by Primary Immunodeficiency Disorder, 2022 - 2028 (USD Billion)
    • 6.5 Secondary Immunodeficiency
      • 6.5.1 Global Plasma Protein Therapeutics Market by Secondary Immunodeficiency, 2022 - 2028 (USD Billion)
    • 6.6 Idiopathic Thrombocytopenic
      • 6.6.1 Global Plasma Protein Therapeutics Market by Idiopathic Thrombocytopenic, 2022 - 2028 (USD Billion)
    • 6.7 Others
      • 6.7.1 Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 7. Plasma Protein Therapeutics Market - Regional Analysis
    • 7.1 Global Plasma Protein Therapeutics Market Regional Overview
    • 7.2 Global Plasma Protein Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
        • 7.3.1.1 North America Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 North America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
      • 7.4.1 North America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
    • 7.5 North America Plasma Protein Therapeutics Market, by Application, 2022 - 2028
      • 7.5.1 North America Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 7.4. Europe
      • 7.4.2 Europe Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
        • 7.4.2.1 Europe Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Europe Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
      • 7.4.1 Europe Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
    • 7.5 Europe Plasma Protein Therapeutics Market, by Application, 2022 - 2028
      • 7.5.1 Europe Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
        • 7.5.3.1 Asia Pacific Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Asia Pacific Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
      • 7.4.1 Asia Pacific Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
    • 7.5 Asia Pacific Plasma Protein Therapeutics Market, by Application, 2022 - 2028
      • 7.5.1 Asia Pacific Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 7.6. Latin America
      • 7.6.4 Latin America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
        • 7.6.4.1 Latin America Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 Latin America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
      • 7.4.1 Latin America Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
    • 7.5 Latin America Plasma Protein Therapeutics Market, by Application, 2022 - 2028
      • 7.5.1 Latin America Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
        • 7.7.5.1 The Middle-East and Africa Plasma Protein Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 7.4 The Middle-East and Africa Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028
      • 7.4.1 The Middle-East and Africa Plasma Protein Therapeutics Market, by Product Type, 2022 - 2028 (USD Billion)
    • 7.5 The Middle-East and Africa Plasma Protein Therapeutics Market, by Application, 2022 - 2028
      • 7.5.1 The Middle-East and Africa Plasma Protein Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Biotest AG
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 CSL Behring
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 Grifols SA
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Octapharma USA Inc.
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Takeda Pharmaceutical Company Ltd
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Bio Products Laboratory
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Shire PLC
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Kedrion SpA
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 China Biologic Products Holdings Inc.
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Baxter
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Plasma Protein Therapeutics Market attractiveness, By Product Type
  • 6. Global Plasma Protein Therapeutics Market attractiveness, By Application
  • 7. Global Plasma Protein Therapeutics Market share by Product Type, 2022 and 2028 (USD Billion)
  • 8. Global Plasma Protein Therapeutics Market by C1 esterase Inhibitors, 2022 - 2028 (USD Billion)
  • 9. Global Plasma Protein Therapeutics Market by Albumins, 2022 - 2028 (USD Billion)
  • 10. Global Plasma Protein Therapeutics Market by Immunoglobulins, 2022 - 2028 (USD Billion)
  • 11. Global Plasma Protein Therapeutics Market by Coagulation Factors, 2022 - 2028 (USD Billion)
  • 12. Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • 13. Global Plasma Protein Therapeutics Market share by Application, 2022 and 2028 (USD Billion)
  • 14. Global Plasma Protein Therapeutics Market by Hereditary Angioedema, 2022 - 2028 (USD Billion)
  • 15. Global Plasma Protein Therapeutics Market by Hemophilia, 2022 - 2028 (USD Billion)
  • 16. Global Plasma Protein Therapeutics Market by Primary Immunodeficiency Disorder, 2022 - 2028 (USD Billion)
  • 17. Global Plasma Protein Therapeutics Market by Secondary Immunodeficiency, 2022 - 2028 (USD Billion)
  • 18. Global Plasma Protein Therapeutics Market by Idiopathic Thrombocytopenic, 2022 - 2028 (USD Billion)
  • 19. Global Plasma Protein Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • 20. Global Plasma Protein Therapeutics Market share, by Region, 2022 and 2028
  • 21. North America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
  • 22. Europe Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
  • 23. Asia Pacific Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
  • 24. Latin America Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)
  • 25. The Middle-East and Africa Plasma Protein Therapeutics Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Plasma Protein Therapeutics Market: Snapshot
  • 2. Drivers of the Plasma Protein Therapeutics Market: impact analysis
  • 3. North America Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 4. North America Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 5. U.S. Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 6. U.S. Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 7. Canada Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 8. Canada Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 9. Europe Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 10. Europe Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 11. Germany Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 12. Germany Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 13. France Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 14. France Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 15. U.K. Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 16. U.K. Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 17. Italy Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 18. Italy Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 19. Spain Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 20. Spain Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 21. Rest of Europe Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 22. Rest of Europe Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 23. Asia Pacific Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 24. Asia Pacific Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 25. China Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 26. China Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 27. Japan Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 28. Japan Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 29. India Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 30. India Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 31. South Korea Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 32. South Korea Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 33. South-East Asia Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 34. South-East Asia Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 35. Rest of Asia Pacific Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 36. Rest of Asia Pacific Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 37. Latin America Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 38. Latin America Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 39. Brazil Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 40. Brazil Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 41. Mexico Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 42. Mexico Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 43. Rest of Latin America Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 44. Rest of Latin America Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 45. The Middle-East and Africa Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 46. The Middle-East and Africa Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 47. GCC Countries Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 48. GCC Countries Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 49. South Africa Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 50. South Africa Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 51. Rest of Middle-East Africa Plasma Protein Therapeutics Market revenue, By Product Type, 2022 - 2028 (USD Billion)
  • 52. Rest of Middle-East Africa Plasma Protein Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)

Methodology

FrequentlyAsked Questions

The global plasma protein therapeutics market is expected to grow due to rising demand for plasma-derived products, increasing prevalence of chronic diseases and immune disorders, advancements in protein therapy technologies, and growing awareness of the therapeutic benefits of plasma proteins.
According to a study, the global plasma protein therapeutics market size was worth around USD 32.05 Billion in 2024 and is expected to reach USD 55.54 Billion by 2034.
The global plasma protein therapeutics market is expected to grow at a CAGR of 6.3% during the forecast period.
North America is expected to dominate the plasma protein therapeutics market over the forecast period.

Leading players in the global plasma protein therapeutics market include Biotest AG, CSL Behring, Grifols SA, Octapharma USA Inc., Takeda Pharmaceutical Company Ltd, Bio Products Laboratory, Shire PLC, Kedrion SpA, China Biologic Products Holdings Inc., Baxter, among others.

The report explores crucial aspects of the plasma protein therapeutics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed